Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Immuno-Spin Trapping-Based Detection of Oxidative Modifications in Cardiomyocytes and Coronary Endothelium in the Progression of Heart Failure in Tgαq*44 Mice.

Tytuł:
Immuno-Spin Trapping-Based Detection of Oxidative Modifications in Cardiomyocytes and Coronary Endothelium in the Progression of Heart Failure in Tgαq*44 Mice.
Autorzy:
Proniewski B; Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland.
Czarny J; Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland.
Khomich TI; Institute of Pharmacology and Biochemistry, NAS of Belarus, Grodno, Belarus.
Kus K; Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland.
Zakrzewska A; Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland.
Chlopicki S; Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland.; Chair of Pharmacology, Jagiellonian University Medical College, Krakow, Poland.
Źródło:
Frontiers in immunology [Front Immunol] 2018 May 07; Vol. 9, pp. 938. Date of Electronic Publication: 2018 May 07 (Print Publication: 2018).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Original Publication: [Lausanne : Frontiers Research Foundation]
MeSH Terms:
Immunoassay*/methods
Oxidation-Reduction*
Spin Trapping*/methods
Endothelium, Vascular/*metabolism
Heart Failure/*etiology
Heart Failure/*metabolism
Myocytes, Cardiac/*metabolism
Animals ; Antioxidants/metabolism ; Biomarkers ; Coronary Vessels/metabolism ; Disease Models, Animal ; Disease Progression ; Female ; Heart Failure/diagnosis ; Immunohistochemistry ; Mice ; Mice, Transgenic ; Oxidative Stress ; Superoxides/metabolism
References:
Histochemistry. 1987;86(6):603-7. (PMID: 3610672)
Clin Chem. 1998 Jan;44(1):148-54. (PMID: 9550572)
Nutr Metab Cardiovasc Dis. 2017 Mar;27(3):201-208. (PMID: 28065503)
Arch Biochem Biophys. 2017 Nov 1;633:118-123. (PMID: 28939102)
Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15565-70. (PMID: 20713697)
Lancet. 2011 Aug 20;378(9792):704-12. (PMID: 21856484)
Clin Chim Acta. 2006 Mar;365(1-2):30-49. (PMID: 16214123)
Free Radic Res. 2015;49(9):1140-6. (PMID: 25968951)
Redox Biol. 2017 Aug;12 :35-49. (PMID: 28212522)
Free Radic Biol Med. 2009 Feb 1;46(3):329-38. (PMID: 19026738)
J Cell Mol Med. 2008 Jan-Feb;12(1):174-86. (PMID: 18194445)
J Mol Cell Cardiol. 2008 Sep;45(3):363-72. (PMID: 18674539)
Redox Biol. 2013 Oct 08;1:483-91. (PMID: 24251116)
J Mol Cell Cardiol. 2012 May;52(5):978-87. (PMID: 22285482)
J Mol Cell Cardiol. 2001 Aug;33(8):1477-91. (PMID: 11448136)
Free Radic Biol Med. 1996;21(4):427-36. (PMID: 8886792)
Free Radic Biol Med. 2010 Apr 15;48(8):983-1001. (PMID: 20116425)
Free Radic Biol Med. 2013 Dec;65:828-37. (PMID: 23978375)
Free Radic Biol Med. 2012 Aug 1;53(3):406-14. (PMID: 22634144)
Free Radic Biol Med. 2013 Oct;63:351-60. (PMID: 23722162)
Hypertension. 2007 Apr;49(4):717-27. (PMID: 17296874)
Eur J Cell Biol. 1990 Feb;51(1):85-95. (PMID: 2328740)
Biochim Biophys Acta. 2014 Feb;1840(2):722-9. (PMID: 23644035)
Free Radic Biol Med. 2004 May 15;36(10):1214-23. (PMID: 15110386)
J Biol Chem. 2005 Nov 11;280(45):37339-48. (PMID: 16150735)
J Am Coll Cardiol. 2003 Jun 18;41(12):2164-71. (PMID: 12821241)
Free Radic Biol Med. 2009 Feb 15;46(4):454-61. (PMID: 19049863)
Nature. 2014 Nov 20;515(7527):431-435. (PMID: 25383517)
Proc Natl Acad Sci U S A. 2010 Oct 19;107(42):18121-6. (PMID: 20921387)
Scand J Clin Lab Invest. 2002;62(6):463-8. (PMID: 12469901)
Methods Enzymol. 1984;105:121-6. (PMID: 6727660)
Circ Heart Fail. 2010 Mar;3(2):306-13. (PMID: 20018955)
Methods Enzymol. 2008;441:1-17. (PMID: 18554526)
Cardiovasc Res. 2017 Oct 1;113(12 ):1441-1452. (PMID: 28957536)
Int J Biochem Cell Biol. 2016 May;74:145-51. (PMID: 26987585)
Redox Biol. 2016 Aug;8:422-9. (PMID: 27203617)
Antioxid Redox Signal. 2004 Jun;6(3):619-29. (PMID: 15130289)
FEBS Lett. 2016 Oct;590(20):3469-3480. (PMID: 27670394)
Nat Methods. 2012 Jul;9(7):671-5. (PMID: 22930834)
Circ Res. 2016 Aug 19;119(5):e39-75. (PMID: 27418630)
J Magn Reson Imaging. 2013 Mar;37(3):669-77. (PMID: 23125067)
Circ Res. 2012 Sep 28;111(8):1091-106. (PMID: 23023511)
Methods Enzymol. 1990;186:464-78. (PMID: 1978225)
Cardiovasc Pathol. 2003 Mar-Apr;12(2):82-90. (PMID: 12684163)
Biochim Biophys Acta. 2015 Apr;1851(4):433-45. (PMID: 25449649)
Front Immunol. 2017 Jun 22;8:719. (PMID: 28690610)
Kardiol Pol. 2013;71(7):730-7. (PMID: 23907907)
Pharmacol Rep. 2015 Aug;67(4):778-85. (PMID: 26321281)
J Biol Chem. 2007 Nov 9;282(45):32640-54. (PMID: 17848555)
Free Radic Biol Med. 2003 Jun 1;34(11):1473-81. (PMID: 12757857)
Ann Transl Med. 2017 Aug;5(16):324. (PMID: 28861421)
J Histochem Cytochem. 2002 Jan;50(1):71-9. (PMID: 11748296)
J Clin Invest. 2001 Jul;108(1):41-50. (PMID: 11435456)
Anal Biochem. 2014 Dec 15;467:1-3. (PMID: 25193447)
J Appl Physiol (1985). 2018 Jan 1;124(1):52-65. (PMID: 28970203)
Arch Biochem Biophys. 1959 May;82(1):70-7. (PMID: 13650640)
Histochem J. 1987 Apr;19(4):225-34. (PMID: 3597137)
Circulation. 2004 Feb 3;109(4):544-9. (PMID: 14744974)
Methods Enzymol. 1985;113:484-90. (PMID: 3003504)
J Biol Chem. 1972 May 25;247(10):3170-5. (PMID: 4623845)
Pharmacol Rep. 2016 Aug;68(4):707-14. (PMID: 27126697)
Trends Pharmacol Sci. 2016 Apr;37(4):318-327. (PMID: 26861575)
Curr Med Chem. 2012;19(16):2504-20. (PMID: 22489713)
Heart Fail Clin. 2009 Oct;5(4):561-77. (PMID: 19631180)
Basic Res Cardiol. 2008 Sep;103(5):417-30. (PMID: 18431525)
Free Radic Biol Med. 2012 Jun 1-15;52(11-12):2312-9. (PMID: 22564528)
Amino Acids. 2010 Nov;39(5):1131-7. (PMID: 20532951)
J Am Coll Cardiol. 2017 Jul 11;70(2):212-229. (PMID: 28683969)
Cardiovasc Res. 2018 Mar 1;114(3):401-408. (PMID: 29040462)
J Appl Physiol (1985). 2017 Aug 1;123(2):326-336. (PMID: 28522765)
Lab Delo. 1986;(12):724-7. (PMID: 2434712)
Free Radic Biol Med. 2017 Aug;109 :114-124. (PMID: 27940350)
Anal Biochem. 1976 May 7;72:248-54. (PMID: 942051)
Aging Cell. 2014 Aug;13(4):765-8. (PMID: 24621297)
Clin Sci (Lond). 2007 Jul;112(9):477-84. (PMID: 17176249)
Free Radic Biol Med. 2002 Aug 1;33(3):364-9. (PMID: 12126758)
Am J Physiol Endocrinol Metab. 2008 Aug;295(2):E456-62. (PMID: 18559982)
Curr Protoc Toxicol. 2005 Jun;Chapter 17:Unit 17.7. (PMID: 23045116)
Circulation. 2017 Mar 7;135(10 ):e146-e603. (PMID: 28122885)
Free Radic Biol Med. 2009 Apr 1;46(7):853-65. (PMID: 19159679)
Eur Rev Med Pharmacol Sci. 2013 Sep;17(17):2302-9. (PMID: 24065222)
FEBS J. 2018 Apr;285(7):1346-1358. (PMID: 29464848)
Free Radic Biol Med. 2008 Aug 1;45(3):321-8. (PMID: 18466775)
Biochim Biophys Acta. 2013 Dec;1832(12 ):2153-61. (PMID: 23959048)
Nat Protoc. 2007;2(3):512-22. (PMID: 17406615)
Oxid Med Cell Longev. 2017;2017:6501046. (PMID: 28698768)
Antioxid Redox Signal. 2015 Nov 10;23(14):1144-70. (PMID: 26415143)
Nat Protoc. 2008;3(1):8-21. (PMID: 18193017)
Contributed Indexing:
Keywords: DMPO; Tgαq*44 murine model; cardiomyocytes; coronary endothelium; heart failure; immuno-spin trapping; oxidative modifications; oxidative stress
Substance Nomenclature:
0 (Antioxidants)
0 (Biomarkers)
11062-77-4 (Superoxides)
Entry Date(s):
Date Created: 20180606 Date Completed: 20190701 Latest Revision: 20190701
Update Code:
20240105
PubMed Central ID:
PMC5949515
DOI:
10.3389/fimmu.2018.00938
PMID:
29867936
Czasopismo naukowe
Recent studies suggest both beneficial and detrimental role of increased reactive oxygen species and oxidative stress in heart failure (HF). However, it is not clear at which stage oxidative stress and oxidative modifications occur in the endothelium in relation to cardiomyocytes in non-ischemic HF. Furthermore, most methods used to date to study oxidative stress are either non-specific or require tissue homogenization. In this study, we used immuno-spin trapping (IST) technique with fluorescent microscopy-based detection of DMPO nitrone adducts to localize and quantify oxidative modifications of the hearts from Tgαq*44 mice; a murine model of HF driven by cardiomyocyte-specific overexpression of Gαq* protein. Tgαq*44 mice and age-matched FVB controls at early, transition, and late stages of HF progression were injected with DMPO in vivo and analyzed ex vivo for DMPO nitrone adducts signals. Progressive oxidative modifications in cardiomyocytes, as evidenced by the elevation of DMPO nitrone adducts, were detected in hearts from 10- to 16-month-old, but not in 8-month-old Tgαq*44 mice, as compared with age-matched FVB mice. The DMPO nitrone adducts were detected in left and right ventricle, septum, and papillary muscle. Surprisingly, significant elevation of DMPO nitrone adducts was also present in the coronary endothelium both in large arteries and in microcirculation simultaneously, as in cardiomyocytes, starting from 10-month-old Tgαq*44 mice. On the other hand, superoxide production in heart homogenates was elevated already in 6-month-old Tgαq*44 mice and progressively increased to high levels in 14-month-old Tgαq*44 mice, while the enzymatic activity of catalase, glutathione reductase, and glutathione peroxidase was all elevated as early as in 4-month-old Tgαq*44 mice and stayed at a similar level in 14-month-old Tgαq*44. In summary, this study demonstrates that IST represents a unique method that allows to quantify oxidative modifications in cardiomyocytes and coronary endothelium in the heart. In Tgαq*44 mice with slowly developing HF, driven by cardiomyocyte-specific overexpression of Gαq* protein, an increase in superoxide production, despite compensatory activation of antioxidative mechanisms, results in the development of oxidative modifications not only in cardiomyocytes but also in coronary endothelium, at the transition phase of HF, before the end-stage disease.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies